M Holdings Securities Inc. Decreases Holdings in Phreesia, Inc. (NYSE:PHR)

M Holdings Securities Inc. cut its stake in Phreesia, Inc. (NYSE:PHR) by 14.3% in the third quarter, Holdings Channel reports. The institutional investor owned 15,000 shares of the company’s stock after selling 2,500 shares during the period. M Holdings Securities Inc.’s holdings in Phreesia were worth $342,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Russell Investments Group Ltd. boosted its position in Phreesia by 1,407.9% in the 1st quarter. Russell Investments Group Ltd. now owns 57,874 shares of the company’s stock valued at $1,385,000 after buying an additional 54,036 shares during the period. ProShare Advisors LLC grew its holdings in Phreesia by 8.6% during the 1st quarter. ProShare Advisors LLC now owns 9,522 shares of the company’s stock worth $228,000 after acquiring an additional 751 shares in the last quarter. State Board of Administration of Florida Retirement System increased its position in Phreesia by 27.0% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 18,709 shares of the company’s stock valued at $448,000 after purchasing an additional 3,980 shares during the period. Bessemer Group Inc. raised its holdings in shares of Phreesia by 312.3% in the 1st quarter. Bessemer Group Inc. now owns 22,143 shares of the company’s stock valued at $530,000 after purchasing an additional 16,773 shares in the last quarter. Finally, Quadrature Capital Ltd bought a new stake in shares of Phreesia in the 1st quarter valued at about $202,000. Institutional investors own 92.10% of the company’s stock.

Insider Buying and Selling

In other Phreesia news, insider Yvonne Hui sold 2,791 shares of the company’s stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $20.92, for a total value of $58,387.72. Following the sale, the insider now owns 27,228 shares in the company, valued at approximately $569,609.76. This represents a 9.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, General Counsel Allison C. Hoffman sold 14,110 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $26.03, for a total transaction of $367,283.30. Following the sale, the general counsel now directly owns 121,003 shares in the company, valued at $3,149,708.09. This trade represents a 10.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 44,107 shares of company stock valued at $1,035,226 over the last 90 days. Insiders own 5.80% of the company’s stock.

Phreesia Stock Performance

Shares of PHR stock opened at $19.87 on Friday. The business has a fifty day moving average of $20.79 and a 200 day moving average of $21.91. Phreesia, Inc. has a 1 year low of $14.55 and a 1 year high of $29.16. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.77 and a quick ratio of 1.77. The firm has a market capitalization of $1.15 billion, a price-to-earnings ratio of -11.04 and a beta of 0.94.

Phreesia (NYSE:PHR) last issued its earnings results on Wednesday, September 4th. The company reported ($0.31) EPS for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.06. Phreesia had a negative return on equity of 39.34% and a negative net margin of 25.73%. The firm had revenue of $102.12 million for the quarter, compared to analyst estimates of $101.76 million. As a group, research analysts expect that Phreesia, Inc. will post -1.23 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Robert W. Baird increased their target price on Phreesia from $31.00 to $34.00 and gave the company an “outperform” rating in a research report on Friday, September 6th. Needham & Company LLC reissued a “buy” rating and set a $29.00 price target on shares of Phreesia in a research report on Thursday, September 5th. Royal Bank of Canada restated a “sector perform” rating and issued a $23.00 price target on shares of Phreesia in a report on Friday, September 27th. Truist Financial boosted their price objective on shares of Phreesia from $29.00 to $31.00 and gave the stock a “buy” rating in a research note on Friday, September 6th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target on shares of Phreesia in a research report on Thursday, September 5th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to MarketBeat, Phreesia has an average rating of “Moderate Buy” and a consensus price target of $29.42.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.